Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

A Randomized Trial of Ixempra Versus Taxol in Adjuvant Therapy of Triple Negative Breast Cancer

ClinicalTrials.gov ID: NCT00789581

Public ClinicalTrials.gov record NCT00789581. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jun 25, 2026, 12:03 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Phase III Study of Doxorubicin/Cyclophosphamide (AC) Followed by Ixabepilone vs. AC Followed by Paclitaxel in Patients With Triple-Negative Early-Stage Breast Cancer

Study identification

NCT ID
NCT00789581
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
SCRI Development Innovations, LLC
Other
Enrollment
614 participants

Conditions and interventions

Conditions

Interventions

  • Doxorubicin Drug
  • Cyclophosphamide Drug
  • Ixabepilone (Ixempra) Drug
  • Paclitaxel (Taxol) Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
Female
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 30, 2008
Primary completion
Nov 30, 2015
Completion
Oct 31, 2016
Last update posted
Jul 1, 2017

2008 – 2016

United States locations

U.S. sites
69
U.S. states
27
U.S. cities
64
Facility City State ZIP Site status
Northeast Alabama Regional Medical Center Anniston Alabama 36207
Cancer Center of Huntsville Huntsville Alabama 35801
Clearview Cancer Institute Huntsville Alabama 35805
University of Southern Alabama Mobile Alabama 36604
Northeast Arkansas Clinic Jonesboro Arkansas 72401
Wilshire Oncology Medical Group La Verne California 91750
New Hope Cancer and Research Institute Pomona California 91767
Eastern Connecticut Hematology Oncology Norwich Connecticut 06360
Aventura Medical Center Aventura Florida 33180
Lynn Cancer Institute Boca Raton Florida 33428
Florida Cancer Care Davie Florida 33328
Holy Cross Hospital Fort Lauderdale Florida 33308
Florida Cancer Specialists Fort Myers Florida 33901
Memorial Regional Cancer Center Hollywood Florida 33021
Integrated Community Oncology Network Jacksonville Florida 32256
Watson Clinic Center for Cancer Care and Research Lakeland Florida 33805
Space Coast Medical Associates Titusville Florida 32796
Piedmont Healthcare Atlanta Georgia 30309
Emory/Winship Cancer Institute Atlanta Georgia 30322
Augusta Oncology Associates Augusta Georgia 30901
Medical Oncology Associates of Augusta Augusta Georgia 30901
Medical College of Georgia Cancer Specialists Augusta Georgia 30912
Northeast Georgia Medical Center Gainesville Georgia 30501
Suburban Hem Onc Lawrenceville Georgia 30045
Mid-Illinois Hematology & Oncology Normal Illinois 61761
Hematology Oncology of the North Shore Skokie Illinois 60076
Oncology Hematology Associates of SW Indiana Evansville Indiana 47714
Hematology Oncology of Indiana Indianapolis Indiana 46260
Providence Medical Group Terre Haute Indiana 47802
Kansas City Cancer Centers Overland Park Kansas 66210
Cotton O'Neil Cancer Center Topeka Kansas 66606
Consultants in Blood Disorders and Cancer Louisville Kentucky 40207
Baton Rouge General Medical Center Baton Rouge Louisiana 70806
Mercy Hospital Portland Maine 04101
Weinberg Cancer Institute at Franklin Square Baltimore Maryland 21237
Center for Cancer and Blood Disorders Bethesda Maryland 20817
Fallon Clinic Worcester Massachusetts 01608
Grand Rapids Clinical Oncology Program Grand Rapids Michigan 49503
Fairview Medical Oncology Clinic Edina Minnesota 55436
St. Louis Cancer Care Chesterfield Missouri 63017
Research Medical Center Kansas City Missouri 64132
St. John's Clinic Springfield Missouri 65804
Methodist Cancer Center Omaha Nebraska 68114
St. Clare's Hospital Oncology and Hematology Denville New Jersey 07834
Hematology Oncology Associates of Northern NJ Morristown New Jersey 07960
Southern Oncology and Hematology Vineland New Jersey 08360
New Mexico Oncology Hematology Consultants Albuquerque New Mexico 87109
Alamance Regional Medical Center Burlington North Carolina 27215
Oncology Hematology Care Cincinnati Ohio 45242
Mid Ohio Oncology/Hematology, Inc./ The Mark H. Zangmeister Center Columbus Ohio 43219
Hematology/Oncology Inc Elyria Ohio 44035
Hickman Cancer Center (Flower Hospital) Sylvania Ohio 43560
University of Pittsburgh Medical Center Pittsburgh Pennsylvania 15213
Bux-Mont Oncology, Fox Chase Cancer Center Rockledge Pennsylvania 18960
Medical University of South Carolina Charleston South Carolina 29425
South Carolina Oncology Associates, PA Columbia South Carolina 29210
Lowcountry Hematology Oncology Mt. Pleasant South Carolina 29464
Coastal Cancer Center Myrtle Beach South Carolina 29572
Spartanburg Regional Medical Center Spartanburg South Carolina 29303
Associates in Hematology Oncology Chattanooga Tennessee 37404
Chattanooga Oncology Hematology Associates Chattanooga Tennessee 37404
Family Cancer Center Collierville Tennessee 38017
Tennessee Oncology, PLLC Nashville Tennessee 37023
Coastal Bend Cancer Center Corpus Christi Texas 78463
Center for Cancer and Blood Disorders Fort Worth Texas 76104
Medical Oncology Methodist Hospital Houston Texas 77030
South Texas Oncology and Hematology San Antonio Texas 78258
Peninsula Cancer Institute Newport News Virginia 23601
Virginia Cancer Institute Richmond Virginia 23235

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00789581, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 1, 2017 · Synced Jun 25, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00789581 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →